Go back

Medicines initiative targets Ebola funding gap

The Innovative Medicines Initiative is to allocate €70 million to research into Ebola, which it says is needed to improve global efforts to prevent further outbreaks.

Proposals can include research on the development of vaccines, diagnostic tests, and treatments, according to an IMI press release from 18 December. Applications will remain open for two years, with five cut off dates for proposals between 2016 and 2018.

The funding for Ebola research was announced in tandem with a standard call for proposals to advance medicine development across seven topics. These include: big data projects on heart disease, and research into childhood cancers, Alzheimer’s and Parkinson’s disease, chronic pain, eye diseases and medicines safety. The deadline for submitting proposals is 17 March 2016.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.